These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30127091)

  • 1. Differential receptor selectivity of the FGF15/FGF19 orthologues determines distinct metabolic activities in
    Hansen AMK; Vienberg SG; Lykkegaard K; Zhao X; Tingqing G; Han D; Zhang X; Thøgersen H; Sass-Ørum K; Tagmose T; Raun K; Andersen B
    Biochem J; 2018 Sep; 475(18):2985-2996. PubMed ID: 30127091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monomeric/dimeric forms of Fgf15/FGF19 show differential activity in hepatocyte proliferation and metabolic function.
    Williams CM; Harper Calderon J; E H; Jimenez Y; Barringer K; Carbonaro M; Molina-Portela MDP; Thurston G; Li Z; Daly C
    FASEB J; 2021 Feb; 35(2):e21286. PubMed ID: 33484478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
    Zhou M; Luo J; Chen M; Yang H; Learned RM; DePaoli AM; Tian H; Ling L
    J Hepatol; 2017 Jun; 66(6):1182-1192. PubMed ID: 28189755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.
    Kurosu H; Choi M; Ogawa Y; Dickson AS; Goetz R; Eliseenkova AV; Mohammadi M; Rosenblatt KP; Kliewer SA; Kuro-O M
    J Biol Chem; 2007 Sep; 282(37):26687-26695. PubMed ID: 17623664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.
    Christidis G; Karatayli E; Hall RA; Weber SN; Reichert MC; Hohl M; Qiao S; Boehm U; Lütjohann D; Lammert F; Karatayli SC
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho.
    Fu T; Kim YC; Byun S; Kim DH; Seok S; Suino-Powell K; Xu HE; Kemper B; Kemper JK
    Mol Endocrinol; 2016 Jan; 30(1):92-103. PubMed ID: 26505219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration.
    Alvarez-Sola G; Uriarte I; Latasa MU; Fernandez-Barrena MG; Urtasun R; Elizalde M; Barcena-Varela M; Jiménez M; Chang HC; Barbero R; Catalán V; Rodríguez A; Frühbeck G; Gallego-Escuredo JM; Gavaldà-Navarro A; Villarroya F; Rodriguez-Ortigosa CM; Corrales FJ; Prieto J; Berraondo P; Berasain C; Avila MA
    Gut; 2017 Oct; 66(10):1818-1828. PubMed ID: 28119353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver.
    Cui G; Martin RC; Jin H; Liu X; Pandit H; Zhao H; Cai L; Zhang P; Li W; Li Y
    J Exp Clin Cancer Res; 2018 Jul; 37(1):136. PubMed ID: 29973237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1β inhibits β-Klotho expression and FGF19 signaling in hepatocytes.
    Zhao Y; Meng C; Wang Y; Huang H; Liu W; Zhang JF; Zhao H; Feng B; Leung PS; Xia Y
    Am J Physiol Endocrinol Metab; 2016 Feb; 310(4):E289-300. PubMed ID: 26670488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Over-expression of Fibroblast Growth Factor 21 Increases Bile Acid Biosynthesis by Opposing FGF15/19 Action.
    Zhang J; Gupte J; Gong Y; Weiszmann J; Zhang Y; Lee KJ; Richards WG; Li Y
    EBioMedicine; 2017 Feb; 15():173-183. PubMed ID: 28041926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiology of FGF15/19.
    Jones SA
    Adv Exp Med Biol; 2012; 728():171-82. PubMed ID: 22396169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte FRS2α is essential for the endocrine fibroblast growth factor to limit the amplitude of bile acid production induced by prandial activity.
    Wang C; Yang C; Chang JY; You P; Li Y; Jin C; Luo Y; Li X; McKeehan WL; Wang F
    Curr Mol Med; 2014; 14(6):703-711. PubMed ID: 25056539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
    Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
    Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fundamentals of FGF19 & FGF21 action in vitro and in vivo.
    Adams AC; Coskun T; Rovira AR; Schneider MA; Raches DW; Micanovic R; Bina HA; Dunbar JD; Kharitonenkov A
    PLoS One; 2012; 7(5):e38438. PubMed ID: 22675463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vertical sleeve gastrectomy improves glucose-insulin homeostasis by enhancing β-cell function and survival via FGF15/19.
    Soares GM; Balbo SL; Bronczek GA; Vettorazzi JF; Marmentini C; Zangerolamo L; Velloso LA; Carneiro EM
    Am J Physiol Endocrinol Metab; 2024 Feb; 326(2):E134-E147. PubMed ID: 38117265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble expression of disulfide bond containing proteins FGF15 and FGF19 in the cytoplasm of Escherichia coli.
    Kong B; Guo GL
    PLoS One; 2014; 9(1):e85890. PubMed ID: 24465767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse FGF15 is the ortholog of human and chick FGF19, but is not uniquely required for otic induction.
    Wright TJ; Ladher R; McWhirter J; Murre C; Schoenwolf GC; Mansour SL
    Dev Biol; 2004 May; 269(1):264-75. PubMed ID: 15081372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF15/19 protein levels in the portal blood do not reflect changes in the ileal FGF15/19 or hepatic CYP7A1 mRNA levels.
    Shang Q; Guo GL; Honda A; Saumoy M; Salen G; Xu G
    J Lipid Res; 2013 Oct; 54(10):2606-14. PubMed ID: 23852734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho.
    Wu X; Weiszmann J; Ge H; Baribault H; Stevens J; Hawkins N; Vonderfecht S; Gardner J; Gupte J; Sheng J; Wang M; Li Y
    J Mol Biol; 2012 Apr; 418(1-2):82-9. PubMed ID: 22370560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of glucocorticoids with FXR/FGF19/FGF21-mediated ileum-liver crosstalk.
    Al-Aqil FA; Monte MJ; Peleteiro-Vigil A; Briz O; Rosales R; González R; Aranda CJ; Ocón B; Uriarte I; de Medina FS; Martinez-Augustín O; Avila MA; Marín JJG; Romero MR
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2927-2937. PubMed ID: 29883717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.